An Investigation into the Clinical Performance of the Medacta Masterloc Stem in patients undergoing Total Hip Replacement Procedures

Not Applicable

Active, not recruiting

• Conditions: Osteoarthritis; total hip arthroplasty; Musculoskeletal - Osteoarthritis; Surgery - Other surgery

• Registration Number: ACTRN12623000586617
• Lead Sponsor: Medacta Australia Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-05-30
• Last Update Posted: 5 June 2023

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

Patients with symptomatic arthritis who are candidates for a primary total hip replacement with an uncemented femoral stem as determined jointly by the surgeon and the patient.
Patients able to give informed consent
Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up

Exclusion Criteria

Patients who have had a previous total hip replacement or hip fusion of the affected hip
Pregnant women or those seeking to become pregnant
Patients with a history of active infection
Patients who are a prisoner, currently being treated for a psychiatric disorder, senile dementia, Alzheimer’s disease, or known alcohol or substance abuse
Patients who are immunologically suppressed

Study & Design

• Study Type: Interventional
• Study Design: Not specified